Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis

[1]  Thiago M. C. Pereira,et al.  Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis , 2013, Lipids in Health and Disease.

[2]  M. Inan,et al.  Protective effect of sildenafil on liver injury induced by intestinal ischemia/reperfusion. , 2013, Journal of pediatric surgery.

[3]  G. Kırkalı,et al.  Different responses of fluvastatin to cholesterol‐induced oxidative modifications in rabbits: evidence for preventive effect against DNA damage , 2013, Cell biochemistry and function.

[4]  D. Casarini,et al.  DNA Damage and Augmented Oxidative Stress in Bone Marrow Mononuclear Cells from Angiotensin-Dependent Hypertensive Mice , 2013, International journal of hypertension.

[5]  T. Pereira,et al.  Effects of Aging and Hypercholesterolemia on Oxidative Stress and DNA Damage in Bone Marrow Mononuclear Cells in Apolipoprotein E-deficient Mice , 2013, International journal of molecular sciences.

[6]  Á. Gava,et al.  Sildenafil restores endothelial function in the apolipoprotein E knockout mouse , 2013, Journal of Translational Medicine.

[7]  L. Pernomian,et al.  Contribution of oxidative stress to endothelial dysfunction in hypertension , 2012, Front. Physio..

[8]  Á. Gava,et al.  Cardiac-Autonomic Imbalance and Baroreflex Dysfunction in the Renovascular Angiotensin-Dependent Hypertensive Mouse , 2012, International journal of hypertension.

[9]  C. Tonini,et al.  The Concurrence of Hypercholesterolemia and Aging Promotes DNA Damage in Apolipoprotein E-Deficient Mice , 2012 .

[10]  G. Aydoğ,et al.  Sildenafil accelerates liver regeneration after partial hepatectomy in rats. , 2012, Transplantation proceedings.

[11]  E. Vasquez,et al.  Cardiovascular Autonomic Imbalance and Baroreflex Dysfunction in the Apolipoprotein E-deficient Mouse , 2012, Cellular Physiology and Biochemistry.

[12]  Á. Gava,et al.  Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse , 2012, Journal of Biomedical Science.

[13]  Thiago M. C. Pereira,et al.  Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and aging , 2011, Lipids in Health and Disease.

[14]  B. Nogueira,et al.  Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice , 2011, Lipids in Health and Disease.

[15]  L. Šoltés,et al.  Pro-oxidative effect of peroxynitrite regarding biological systems: a special focus on high-molar-mass hyaluronan degradation. , 2011, General physiology and biophysics.

[16]  F. Pashkow.  Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention? , 2011, International journal of inflammation.

[17]  P. Di Mascio,et al.  DNA strand breaks and base modifications induced by cholesterol hydroperoxides , 2011, Free radical research.

[18]  P. Dent,et al.  Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction , 2010, Proceedings of the National Academy of Sciences.

[19]  Shou-Dong Lee,et al.  Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability. , 2010, Clinical science.

[20]  A. Jyothy,et al.  Application of the comet assay for assessment of oxidative DNA damage in circulating lymphocytes of Tetralogy of Fallot patients. , 2010, Mutation research.

[21]  C. Schneider.  Lipids in health and disease. , 2010, Molecular nutrition & food research.

[22]  C. Gennings,et al.  Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells , 2010, Breast Cancer Research and Treatment.

[23]  A. Rivard,et al.  Sildenafil Increases Endothelial Progenitor Cell Function and Improves Ischemia-Induced Neovascularization in Hypercholesterolemic Apolipoprotein E–Deficient Mice , 2009, Hypertension.

[24]  M. Ghasemi,et al.  Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism. , 2009, Canadian journal of physiology and pharmacology.

[25]  S. Biswal,et al.  Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. , 2009, The Journal of urology.

[26]  A. Dhawan,et al.  Comet assay: a reliable tool for the assessment of DNA damage in different models , 2009, Cell Biology and Toxicology.

[27]  M. Fitó,et al.  Olive oil and oxidative stress. , 2007, Molecular nutrition & food research.

[28]  P. Møller,et al.  Oxidatively damaged DNA and inflammation in the liver of dyslipidemic ApoE-/- mice exposed to diesel exhaust particles. , 2007, Toxicology.

[29]  P. Møller,et al.  Oxidatively damaged DNA in aging dyslipidemic ApoE-/- and wild-type mice. , 2007, Mutagenesis.

[30]  I. Komuro,et al.  Vascular Cell Senescence: Contribution to Atherosclerosis , 2007, Circulation research.

[31]  M. Bennett,et al.  DNA damage and repair in atherosclerosis. , 2006, Cardiovascular research.

[32]  R. Groszmann,et al.  Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers. , 2006, Journal of hepatology.

[33]  H. Homayoun,et al.  The proconvulsant effect of sildenafil in mice: role of nitric oxide–cGMP pathway , 2006, British journal of pharmacology.

[34]  G. Angelini,et al.  Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells , 2005, British journal of pharmacology.

[35]  R. Persad,et al.  Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells , 2005, BJU international.

[36]  S. Nikfar,et al.  Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. , 2005, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[37]  C. S. Patil,et al.  Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. , 2004, Methods and findings in experimental and clinical pharmacology.

[38]  S. Manfredini,et al.  The antioxidants and pro-antioxidants network: an overview. , 2004, Current pharmaceutical design.

[39]  M. Andreassi,et al.  DNA damage as a new emerging risk factor in atherosclerosis. , 2003, Trends in cardiovascular medicine.

[40]  T. V. van Berkel,et al.  Aorta of ApoE-Deficient Mice Responds to Atherogenic Stimuli by a Prelesional Increase and Subsequent Decrease in the Expression of Antioxidant Enzymes , 2003, Circulation research.

[41]  P. Duez,et al.  Statistics of the Comet assay: a key to discriminate between genotoxic effects. , 2003, Mutagenesis.

[42]  G. Muirhead,et al.  Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. , 2002, British journal of clinical pharmacology.

[43]  D M Essayan,et al.  Cyclic nucleotide phosphodiesterases. , 2001, The Journal of allergy and clinical immunology.

[44]  J. Dewitte,et al.  Comet assay and early apoptosis. , 2001, Mutation research.

[45]  M. Colasanti,et al.  The dual personality of NO. , 2000, Trends in pharmacological sciences.

[46]  G. Kojda,et al.  Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. , 1999, Cardiovascular research.

[47]  Pierre Lebailly,et al.  Early detection of staurosporine-induced apoptosis by comet and annexin V assays , 1999, Histochemistry and Cell Biology.

[48]  M. Kirsch‐Volders,et al.  Development and validation of the in vivo alkaline comet assay for detecting genomic damage in marine flatfish. , 1998, Mutation research.

[49]  N. Maeda,et al.  Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. , 1994, The Journal of clinical investigation.

[50]  H. Esterbauer,et al.  Cytotoxicity and genotoxicity of lipid-oxidation products. , 1993, The American journal of clinical nutrition.

[51]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[52]  S. Ozkanlar,et al.  Antioxidant vitamins in atherosclerosis--animal experiments and clinical studies. , 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[53]  G. Poli,et al.  Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. , 2012, Free radical biology & medicine.

[54]  C. Stefanadis,et al.  Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies , 2011, Heart Failure Reviews.

[55]  Shao Ju-fang,et al.  The p53-mediated apoptosis in hypercholesterolemia-induced renal injury of rats , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[56]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[57]  H. Yin,et al.  New insights regarding the autoxidation of polyunsaturated fatty acids. , 2005, Antioxidants & redox signaling.

[58]  M. Andreassi.  Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. , 2003, Mutation research.

[59]  A. Izzotti.  DNA damage and alterations of gene expression in chronic-degenerative diseases. , 2003, Acta biochimica Polonica.

[60]  P. Wright,et al.  Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[61]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[62]  M. Dizdaroglu.  Chemical determination of free radical-induced damage to DNA. , 1991, Free radical biology & medicine.